CN103926241B - 一种新型检测试纸条及其制备与应用 - Google Patents
一种新型检测试纸条及其制备与应用 Download PDFInfo
- Publication number
- CN103926241B CN103926241B CN201410158121.9A CN201410158121A CN103926241B CN 103926241 B CN103926241 B CN 103926241B CN 201410158121 A CN201410158121 A CN 201410158121A CN 103926241 B CN103926241 B CN 103926241B
- Authority
- CN
- China
- Prior art keywords
- substrate
- test
- detection
- test strip
- paper plate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 134
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 238000001514 detection method Methods 0.000 claims abstract description 62
- 239000000758 substrate Substances 0.000 claims abstract description 52
- 238000004026 adhesive bonding Methods 0.000 claims abstract description 8
- 239000003292 glue Substances 0.000 claims abstract description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 29
- 210000002700 urine Anatomy 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 238000005520 cutting process Methods 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 3
- 241001463139 Vitta Species 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 108010015776 Glucose oxidase Proteins 0.000 claims description 2
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 102000003992 Peroxidases Human genes 0.000 claims description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
- XKNKHVGWJDPIRJ-UHFFFAOYSA-N arsanilic acid Chemical compound NC1=CC=C([As](O)(O)=O)C=C1 XKNKHVGWJDPIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 229950002705 arsanilic acid Drugs 0.000 claims description 2
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 2
- 229940083618 sodium nitroprusside Drugs 0.000 claims description 2
- UWOLEGVHCLTYCB-UHFFFAOYSA-N n-benzo[g]quinolin-4-yl-n',n'-diethylethane-1,2-diamine Chemical compound C1=CC=C2C=C3C(NCCN(CC)CC)=CC=NC3=CC2=C1 UWOLEGVHCLTYCB-UHFFFAOYSA-N 0.000 claims 1
- 239000000123 paper Substances 0.000 description 58
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 230000028327 secretion Effects 0.000 description 11
- 210000003296 saliva Anatomy 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 9
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229960003299 ketamine Drugs 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 6
- 238000007639 printing Methods 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000013100 final test Methods 0.000 description 4
- 229960005181 morphine Drugs 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 108010000849 leukocyte esterase Proteins 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- 108010006232 Neuraminidase Proteins 0.000 description 2
- 102000005348 Neuraminidase Human genes 0.000 description 2
- 208000037009 Vaginitis bacterial Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 235000021393 food security Nutrition 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000005000 reproductive tract Anatomy 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- -1 sialic acid glycosides Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XUDUTRMKKYUAKI-UHFFFAOYSA-N 3-[1-(1-phenylethyl)piperidin-4-yl]-1h-benzimidazol-2-one Chemical compound C1CC(N2C(NC3=CC=CC=C32)=O)CCN1C(C)C1=CC=CC=C1 XUDUTRMKKYUAKI-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010038669 Respiratory arrest Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 239000000150 Sympathomimetic Substances 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000003555 analeptic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 208000005882 cadmium poisoning Diseases 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960001252 methamphetamine Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- 229950010883 phencyclidine Drugs 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 208000017443 reproductive system disease Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000013522 software testing Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001975 sympathomimetic effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410158121.9A CN103926241B (zh) | 2014-04-18 | 2014-04-18 | 一种新型检测试纸条及其制备与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410158121.9A CN103926241B (zh) | 2014-04-18 | 2014-04-18 | 一种新型检测试纸条及其制备与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103926241A CN103926241A (zh) | 2014-07-16 |
CN103926241B true CN103926241B (zh) | 2016-08-17 |
Family
ID=51144539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410158121.9A Active CN103926241B (zh) | 2014-04-18 | 2014-04-18 | 一种新型检测试纸条及其制备与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103926241B (zh) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104697993A (zh) * | 2015-02-10 | 2015-06-10 | 吴有财 | 一种尿液数据采集装置及其使用方法 |
CN104697938B (zh) * | 2015-03-21 | 2018-04-20 | 重庆早柒天生物科技股份有限公司 | 一种试纸读取方法及使用该方法进行验孕和排卵的测试方法 |
CN106296762A (zh) * | 2015-06-29 | 2017-01-04 | 通用电气公司 | 医学检查报告生成方法 |
CN106053822B (zh) * | 2015-07-16 | 2017-10-03 | 广西华银医学检验所有限公司 | 血液诊断测试盒 |
CN105388147A (zh) * | 2015-10-21 | 2016-03-09 | 深圳市宝凯仑生物科技有限公司 | 一种基于专用试纸对体液的检测方法 |
CN105784697A (zh) * | 2016-03-07 | 2016-07-20 | 苏州卡睿知光电科技有限公司 | 一种试纸检测装置 |
CN105973885B (zh) * | 2016-05-27 | 2019-06-28 | 宋秀龙 | 一种基于颜色识别的快速检测系统的快速干化学检测方法 |
CN106290327A (zh) * | 2016-07-22 | 2017-01-04 | 苏州汶颢芯片科技有限公司 | 重金属离子检测芯片及其检测方法 |
CN106124748A (zh) * | 2016-07-27 | 2016-11-16 | 柳州康云互联科技有限公司 | 用于移动端的尿常规检测传感器 |
CN106546581B (zh) * | 2016-11-02 | 2019-12-10 | 长沙云知检信息科技有限公司 | 试纸检测卡智能检测系统以及试纸检测卡智能分析方法 |
CN108732167A (zh) * | 2017-04-17 | 2018-11-02 | 天津大学 | 用纸质检测装置对多氯联苯总量进行快速现场检测的方法 |
CN109142339A (zh) * | 2018-07-21 | 2019-01-04 | 贾晓轻 | 临床诊断试剂盒以及使用方法 |
CN109187518A (zh) * | 2018-08-04 | 2019-01-11 | 贾晓轻 | 一种临床诊断试剂盒 |
TWI666439B (zh) * | 2018-09-04 | 2019-07-21 | 東吳大學 | 一種檢測白血球酯酶的檢測裝置 |
CN109358190A (zh) * | 2018-11-16 | 2019-02-19 | 许金芹 | 一种内分泌科智能血尿检装置 |
WO2021081083A1 (en) * | 2019-10-21 | 2021-04-29 | Veriteque Usa Inc. | Detection of nicotine, cannabinoids and drugs of abuse on vaping device surfaces and vaping liquid formulations |
CN111443204A (zh) * | 2020-02-25 | 2020-07-24 | 古镜科技(深圳)有限公司 | 一种毛发中毒品荧光三联检试纸条及其制备方法 |
CN111505269B (zh) * | 2020-04-30 | 2024-03-29 | 广东康盾创新产业集团股份公司 | 一种免疫层析分析仪器 |
CN112147134A (zh) * | 2020-09-15 | 2020-12-29 | 江苏宜偌维盛生物技术有限公司 | 体外诊断试剂半定量辅助判读系统 |
CN112147135A (zh) * | 2020-09-15 | 2020-12-29 | 江苏宜偌维盛生物技术有限公司 | 体外诊断试剂检测卡比色辅助判读系统 |
WO2022088567A1 (zh) * | 2020-10-30 | 2022-05-05 | 厦门波耐模型设计有限责任公司 | 集成化试纸检测方法、装置及其制备工艺 |
CN112362648B (zh) * | 2020-10-30 | 2021-11-26 | 厦门波耐模型设计有限责任公司 | 集成化检测试纸及其制备工艺 |
CN112505032A (zh) * | 2020-12-10 | 2021-03-16 | 厦门禾堂餐饮企业管理有限公司 | 一种食品智能检测装置 |
CN114778451A (zh) * | 2022-05-26 | 2022-07-22 | 安徽工业大学 | 一种食品色素的多模裸眼检测数字化颜色信息卡、制备方法及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3133826A1 (de) * | 1981-08-27 | 1983-03-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | Analyseteststreifen und verfahren zu seiner herstellung |
US6770487B2 (en) * | 2001-05-01 | 2004-08-03 | Ischemia Technologies, Inc. | Bar code readable diagnostic strip test |
CN1389728A (zh) * | 2002-06-25 | 2003-01-08 | 桂林市医疗电子仪器厂 | 具有识别标识的干式多项试纸 |
CN1251127C (zh) * | 2003-04-10 | 2006-04-12 | 力捷电脑股份有限公司 | 试片检验区检测结果自动侦测方法 |
WO2009063379A1 (en) * | 2007-11-12 | 2009-05-22 | Koninklijke Philips Electronics N. V. | Optical bio-sensor cartridge identifier |
CN202275081U (zh) * | 2011-04-25 | 2012-06-13 | 刘静 | 一种带有条码功能的新型试纸 |
CN102519959B (zh) * | 2011-12-15 | 2014-05-07 | 上海馨晟试化工科技有限公司 | 一种高灵敏度的pH试纸及其制备方法 |
CN202453295U (zh) * | 2012-01-09 | 2012-09-26 | 邯郸派瑞电器有限公司 | 一种甲醛快速检测试纸 |
CN203396705U (zh) * | 2013-05-13 | 2014-01-15 | 深圳市宝凯仑科技有限公司 | 一种快速检测卡 |
-
2014
- 2014-04-18 CN CN201410158121.9A patent/CN103926241B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103926241A (zh) | 2014-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103926241B (zh) | 一种新型检测试纸条及其制备与应用 | |
Ates et al. | Integrated devices for non‐invasive diagnostics | |
US11543408B2 (en) | Device and system for analyzing a sample, particularly blood, as well as methods of using the same | |
CN113376364B (zh) | 步骤简化、小样品、快速、易使用的生物/化学分析装置和方法 | |
CN111107939B (zh) | 引导有害污染物样品的收集的系统和模板及使用其的方法 | |
US6426227B1 (en) | Method for analyzing secreted bodily fluids | |
JP2016508610A (ja) | 検定結果を収集及び送信するためのシステム並びに方法 | |
NZ571425A (en) | Microfluidic chamber assembly for mastitis assay with wedge shaped chamber | |
CN106662573B (zh) | 用于确定尿液中的分析物和/或化学-物理参数、以及确定尿液中尿沉淀的容器;以及使用该容器进行全尿分析的方法 | |
US20220331797A1 (en) | Micromixer | |
US7455813B2 (en) | Compact analyte testing cassette with true positive and negative analyte controls | |
CN102164531A (zh) | 一个通用的医疗诊断测试平台和读取测试平台的设备 | |
US20090042313A1 (en) | Recording assay device | |
Kierkegaard et al. | Rapid point-of-care testing for COVID-19: quality of supportive information for lateral flow serology assays | |
World Health Organization | Tests for glucose-6-phosphate dehydrogenase activity: target product profiles | |
EP1413888A1 (en) | Clinical examination analyzing device, clinical examination analyzing method and clinical examination analyzing program | |
US20050112547A1 (en) | Vaginal infection test system and method | |
US11480563B2 (en) | Medical test card | |
US20230084255A1 (en) | Test strip for detecting analyte in sample | |
CN103045468A (zh) | 用于检测幽门螺杆菌感染的试剂盒 | |
US20190240654A1 (en) | Method and apparatus for mutli-channel urinalysis test kit with multi-factor control | |
US20040053417A1 (en) | Diagnostic device and method of using same | |
CN108872229A (zh) | 一种新型尿液检测设备 | |
EP3743723A2 (en) | Medical test card | |
US11878297B2 (en) | Fluid specimen testing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230614 Address after: 5 / F, building 3, Dongguan Taiwan Biotechnology cooperation and breeding center, No.1 Taoyuan Road, Taiwan hi tech park, Songshanhu hi tech Industrial Development Zone, Dongguan City, Guangdong Province, 523000 Patentee after: GUANGDONG PAITE AIER BIOTECHNOLOGY CO.,LTD. Address before: 518109 4th floor, A2 workshop, Mingjun Industrial Park, Huaning Road, Longhua Dalang street, Bao'an District, Shenzhen City, Guangdong Province Patentee before: SHENZHEN BIOCHEMILOGIC TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |